Puerarin Alleviates UUO-Induced Inflammation and Fibrosis by Regulating the NF-κB P65/STAT3 and TGFβ1/Smads Signaling Pathways

References

• LvJC, ZhangLX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3–15.31399958
   PubMed Web of Science ®Google Scholar
• BülowRD, BoorP. Extracellular matrix in kidney fibrosis: more than just a scaffold. J Histochem Cytochem. 2019;67(9):643–661. doi:10.1369/002215541984938831116062
   PubMed Web of Science ®Google Scholar
• MackM. Inflammation and fibrosis. Mat Biol. 2018;68–69:106–121. doi:10.1016/j.matbio.2017.11.010
   PubMed Web of Science ®Google Scholar
• SalminenA. Increased immunosuppression impairs tissue homeostasis with aging and age-related diseases. J Mol Med. 2021;99(1):1–20. doi:10.1007/s00109-020-01988-733025106
   PubMed Web of Science ®Google Scholar
• ZhangH, SunSC. NF-κB in inflammation and renal diseases. Cell Biosci. 2015;5(1):63. doi:10.1186/s13578-015-0056-426579219
   PubMed Web of Science ®Google Scholar
• LawrenceT. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651. doi:10.1101/cshperspect.a00165120457564
   PubMed Web of Science ®Google Scholar
• HoeselB, SchmidJA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013;12(1):86. doi:10.1186/1476-4598-12-8623915189
   PubMed Web of Science ®Google Scholar
• MussbacherM, SalzmannM, BrostjanC, et al. Cell type-specific roles of NF-κB linking inflammation and thrombosis. Front Immunol. 2019;10:85.30778349
   PubMed Web of Science ®Google Scholar
• TaniguchiK, KarinM. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309–324.29379212
   PubMed Web of Science ®Google Scholar
• ZhongL, SimardMJ, HuotJ. Endothelial microRNAs regulating the NF-κB pathway and cell adhesion molecules during inflammation. FASEB J. 2018;32(8):4070–4084. doi:10.1096/fj.201701536R29565737
   PubMed Web of Science ®Google Scholar
• RenQ, GuoF, TaoS, HuangR, MaL, FuP. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice. Biomed Pharmacother. 2020;122:109772. doi:10.1016/j.biopha.2019.10977231918290
   PubMed Web of Science ®Google Scholar
• KaruppagounderV, ArumugamS, ThandavarayanRA, et al. Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NFκB p65 mediated inflammation. Int Immunopharmacol. 2015;28(1):154–159. doi:10.1016/j.intimp.2015.05.05026072060
   PubMed Web of Science ®Google Scholar
• TianL, LiW, YangL, et al. Cannabinoid receptor 1 participates in liver inflammation by promoting M1 macrophage polarization via rhoA/NF-κB p65 and ERK1/2 pathways, respectively, in mouse liver fibrogenesis. Front Immunol. 2017;8:1214. doi:10.3389/fimmu.2017.0121429033935
   PubMed Web of Science ®Google Scholar
• FuYJ, XuB, HuangSW, et al. Baicalin prevents LPS-induced activation of TLR4/NF-κB p65 pathway and inflammation in mice via inhibiting the expression of CD14. Acta Pharmacol Sin. 2021;42(1):88–96. doi:10.1038/s41401-020-0411-932457419
   PubMed Web of Science ®Google Scholar
• ChadeAR, WilliamsML, EngelJE, WilliamsE, BidwellGL3rdMolecular targeting of renal inflammation using drug delivery technology to inhibit NF-κB improves renal recovery in chronic kidney disease. Am J Physiol Renal Physiol. 2020;319(1):F139–f148. doi:10.1152/ajprenal.00155.202032538151
   PubMed Web of Science ®Google Scholar
• LiZL, ShiY, LeG, et al. 24-week exposure to oxidized tyrosine induces hepatic fibrosis involving activation of the MAPK/TGF-β1 signaling pathway in sprague-dawley rats model. Oxid Med Cell Longev. 2016;2016:3123294.26788244
   PubMed Web of Science ®Google Scholar
• KimKK, SheppardD, ChapmanHA. TGF-β1 signaling and tissue fibrosis. Cold Spring Harb Perspect Biol. 2018;10(4):a022293. doi:10.1101/cshperspect.a02229328432134
   PubMed Web of Science ®Google Scholar
• NiSY, ZhongXL, LiZH, et al. Puerarin alleviates lipopolysaccharide-induced myocardial fibrosis by inhibiting PARP-1 to prevent HMGB1-mediated TLR4-NF-κB signaling pathway. Cardiovasc Toxicol. 2020;20(5):482–491.32236896
   PubMed Web of Science ®Google Scholar
• NiuL, LuoR, ZouM, et al. Puerarin inhibits mycoplasma gallisepticum (MG-HS)-induced inflammation and apoptosis via suppressing the TLR6/MyD88/NF-κB signal pathway in chicken. Int Immunopharmacol. 2020;88:106993. doi:10.1016/j.intimp.2020.10699333182066
   PubMed Web of Science ®Google Scholar
• ChenX, HuangC, SunH. Puerarin suppresses inflammation and ECM degradation through Nrf2/HO-1 axis in chondrocytes and alleviates pain symptom in osteoarthritic mice. Food Funct. 2021;12(5):2075–2089. doi:10.1039/D0FO03076G33543180
   PubMed Web of Science ®Google Scholar
• GuoCJ, XieJJ, HongRH, PanHS, ZhangFG, LiangYM. Puerarin alleviates streptozotocin (STZ)-induced osteoporosis in rats through suppressing inflammation and apoptosis via HDAC1/HDAC3 signaling. Biomed Pharmacother. 2019;115:108570. doi:10.1016/j.biopha.2019.01.03131054509
   PubMed Web of Science ®Google Scholar
• HeL, WangT, ChenBW, LuFM, XuJ. Puerarin inhibits apoptosis and inflammation in myocardial cells via PPARα expression in rats with chronic heart failure. Exp Ther Med. 2019;18(5):3347–3356.31602208
   PubMed Web of Science ®Google Scholar
• ChangX, ZhangT, LiuD, et al. Puerarin attenuates LPS-induced inflammatory responses and oxidative stress injury in human umbilical vein endothelial cells through mitochondrial quality control. Oxid Med Cell Longev. 2021;2021:6659240. doi:10.1155/2021/665924033728025
   PubMed Web of Science ®Google Scholar
• ZhangL, XuX, YangR, et al. Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling. Drug Des Devel Ther. 2015;9:2139–2148. doi:10.2147/DDDT.S81390
   PubMed Web of Science ®Google Scholar
• ZhangD, SunL, XianW, et al. Low-dose paclitaxel ameliorates renal fibrosis in rat UUO model by inhibition of TGF-beta/smad activity. Lab Invest. 2010;90(3):436–447. doi:10.1038/labinvest.2009.14920142807
   PubMed Web of Science ®Google Scholar
• ChoiDE, JeongJY, LimBJ, et al. Aliskiren ameliorates renal inflammation and fibrosis induced by unilateral ureteral obstruction in mice. J Urol. 2011;186(2):694–701. doi:10.1016/j.juro.2011.03.12221683401
   PubMed Web of Science ®Google Scholar
• KimD, LeeAS, JungYJ, et al. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/smad signaling pathway. Nephrol Dial Transplant. 2014;29(11):2043–2053. doi:10.1093/ndt/gfu24025031017
   PubMed Web of Science ®Google Scholar
• WuT, LiuT, XingL, JiG. Baicalin and puerarin reverse epithelial-mesenchymal transition via the TGF-β1/smad3 pathway in vitro. Exp Ther Med. 2018;16(3):1968–1974.30186426
   PubMed Web of Science ®Google Scholar
• SheS, LiuW, LiT, HongY. Effects of puerarin in STZ-induced diabetic rats by oxidative stress and the TGF-β1/smad2 pathway. Food Funct. 2014;5(5):944–950. doi:10.1039/C3FO60565E24595557
   PubMed Web of Science ®Google Scholar
• ChenR, XueJ, XieM. Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-β1 expression. J Nutr Biochem. 2012;23(9):1080–1085. doi:10.1016/j.jnutbio.2011.05.01522079205
   PubMed Web of Science ®Google Scholar
• JinYG, YuanY, WuQQ, et al. Puerarin protects against cardiac fibrosis associated with the inhibition of TGF-β1/smad2-mediated endothelial-to-mesenchymal transition. PPAR Res. 2017;2017:2647129. doi:10.1155/2017/264712928638404
   PubMed Web of Science ®Google Scholar
• XuX, ZhengN, ChenZ, HuangW, LiangT, KuangH. Puerarin, isolated from Pueraria lobata (Willd.), protects against diabetic nephropathy by attenuating oxidative stress. Gene. 2016;591(2):411–416. doi:10.1016/j.gene.2016.06.03227317894
   PubMed Web of Science ®Google Scholar
• LiuMW, LiuR, WuHY, et al. Radix puerariae extracts ameliorate paraquat-induced pulmonary fibrosis by attenuating follistatin-like 1 and nuclear factor erythroid 2p45-related factor-2 signalling pathways through downregulation of miRNA-21 expression. BMC Complement Altern Med. 2016;16(1):11. doi:10.1186/s12906-016-0991-626758514
   PubMed Web of Science ®Google Scholar
• NewtonK, DixitVM. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol. 2012;4(3):a006049–a006049. doi:10.1101/cshperspect.a00604922296764
   PubMed Web of Science ®Google Scholar
• CalòV, MigliavaccaM, BazanV, et al. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol. 2003;197(2):157–168. doi:10.1002/jcp.1036414502555
   PubMed Web of Science ®Google Scholar
• AlbrechtU, YangX, AsseltaR, et al. Activation of NF-kappaB by IL-1beta blocks IL-6-induced sustained STAT3 activation and STAT3-dependent gene expression of the human gamma-fibrinogen gene. Cell Signal. 2007;19(9):1866–1878. doi:10.1016/j.cellsig.2007.04.00717543500
   PubMed Web of Science ®Google Scholar
• BodeJG, FischerR, HäussingerD, GraeveL, HeinrichPC, SchaperF. The inhibitory effect of IL-1 beta on IL-6-induced alpha 2-macroglobulin expression is due to activation of NF-kappa B. J Immunol. 2001;167(3):1469–1481. doi:10.4049/jimmunol.167.3.146911466367
   PubMed Web of Science ®Google Scholar
• BodeJG, AlbrechtU, HäussingerD, HeinrichPC, SchaperF. Hepatic acute phase proteins–regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling. Eur J Cell Biol. 2012;91(6–7):496–505. doi:10.1016/j.ejcb.2011.09.00822093287
   PubMed Web of Science ®Google Scholar
• ZhangZ, FullerGM. The competitive binding of STAT3 and NF-kappaB on an overlapping DNA binding site. Biochem Biophys Res Commun. 1997;237(1):90–94. doi:10.1006/bbrc.1997.70829266835
   PubMed Web of Science ®Google Scholar
• ZhangZ, FullerGM. Interleukin 1beta inhibits interleukin 6-mediated rat gamma fibrinogen gene expression. Blood. 2000;96(10):3466–3472. doi:10.1182/blood.V96.10.346611071643
   PubMed Web of Science ®Google Scholar
• YoshidaY, KumarA, KoyamaY, et al. Interleukin 1 activates STAT3/nuclear factor-kappaB cross-talk via a unique TRAF6- and p65-dependent mechanism. J Biol Chem. 2004;279(3):1768–1776. doi:10.1074/jbc.M31149820014593105
   PubMed Web of Science ®Google Scholar
• MaX, YanL, ZhuQ, ShaoF. Puerarin attenuates cisplatin-induced rat nephrotoxicity: the involvement of TLR4/NF-κB signaling pathway. PLoS One. 2017;12(2):e0171612. doi:10.1371/journal.pone.017161228182789
   PubMed Web of Science ®Google Scholar